Platelet chemokines and their receptors: What is their relevance to platelet storage and transfusion practice?

Transfusion Medicine

Volumn 11, Issue 6, 2001, Pages 403-417

  Boehlen, F ^a   Clemetson, K J ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Chemokine receptors; Chemokines; Platelet storage; Platelet transfusion; Platelets

Indexed keywords

BETA THROMBOGLOBULIN; CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CXCR4; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; HEPARIN; INTERLEUKIN 8; RANTES; THROMBOCYTE FACTOR 4;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONGESTIVE HEART FAILURE; HUMAN; INFLAMMATORY CELL; INFLAMMATORY DISEASE; MEGAKARYOCYTE; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ANIMALS; BLOOD PLATELETS; BLOOD PRESERVATION; CHEMOKINES; HUMANS; PLATELET ACTIVATION; PLATELET TRANSFUSION; RECEPTORS, CHEMOKINE;

EID: 0035673503     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2001.00340.x     Document Type: Review

References (139)

1. The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques
2. Clinical trial and local process evaluation of an apheresis system for preparation of white cell-reduced platelet components
3. RANTES is as chemotactic and activating factor for human eosinophils
4. Antigens involved in heparin-induced thrombocytopenia
5. Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells
6. Circulating levels of RANTES in human immunodeficiency virus type 1 infection: Effect of potent antiretroviral therapy
7. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage
8. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
9. Human chemokines: An update
10. In vitro effects of platelet factor 4 on normal human neutrophil functions
11. Complete covalent structure of human beta-thromboglobulin
12. Chemokine receptors as HIV coreceptors: Roles in viral entry, tropism, and disease
13. RANTES and related chemokines activate human basophil granulocytes through different G protein-coupled receptors
14. A clinical and laboratory study of platelet concentrates produced by pooled buffy coat and single donor apheresis technologies
15. Storage of single-donor platelet concentrates: Metabolic and functional changes
16. Platelet-derived CXC chemokines: Old players in new games
17. The beta-thromboglobulins and platelet factor 4: Blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation
18. Chemokines in stored platelet concentrates
19. Platelet-leukocyte-endothelial cell interaction on the blood vessel wall
20. Heparin-induced thrombocytopenia
21. Pathophysiology and laboratory testing of heparin-induced thrombocytopenia
22. Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets
23. More on kininogen measurements in platelet concentrates that are white cell (WBC) reduced with WBC-reduction filters
24. Requirement of MIP-1 alpha for an inflammatory response to viral infection
25. Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine
26. High activity suppression of myeloid progenitor proliferation by chimeric mutants of interleukin 8 and platelet factor 4
27. Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure
28. CXC-chemokines, a new group of cytokines in congestive heart failure - Possible role of platelets and monocytes
29. Inflammatory effects of leukocytes and platelets
30. Amino acid sequence of human platelet factor 4
31. Platelet factor 4 is chemotactic for neutrophils and monocytes
32. Down-regulation of neutrophil functions by the ELR(+) CXC chemokine platelet basic protein
33. Heparin-induced thrombocytopenia: Laboratory diagnosis and management
34. Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage
35. Detection of platelet activation with monoclonal antibodies and flow cytometry. Changes during platelet storage
36. Platelet activation during preparation of platelet concentrates: A comparison of the platelet-rich plasma and the buffy coat methods
37. Effects of filtration and gamma radiation on the accumulation of RANTES and transforming growth factor-betal in apheresis platelet concentrates during storage
38. Generation of interleukin 8 in stored apheresis platelet concentrates and the preventive effect of prestorage ultraviolet B radiation
39. Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function
40. Removal of anaphylatoxins C3a and C5a and chemokines interleukin 8 and RANTES by polyester white cell-reduction and plasma filters
41. Heparin-induced thrombocytopenia - Pathogenesis and treatment
42. Stromal cell-derived factor-1 alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells
43. From malaria to chemokine receptor: The emerging physiologic role of the Duffy blood group antigen
44. Negative regulation of human megakaryocytopoiesis by human platelet factor 4 (PF4) and connective tissue-activating peptide (CTAP-III)
45. Pathophysiology of febrile nonhemolytic tranfsusion reactions
46. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions
47. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets
48. Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4
49. The role of the plasma from platelet concentrates in transfusion reactions
50. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)
51. Enhanced activation of platelets with abnormal release of RANTES in human immunodeficiency virus type 1 infection
52. Characterization of human platelet basic protein, a precursor form of low-affinity platelet factor 4 and beta-thromboglobulin
53. A receptor for the malarial parasite Plasmodium vivax; the erythrocyte chemokine receptor
54. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium
55. A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells
56. Leukocyte-derived growth factor links the PDGF and CXC chemokine families of peptides
57. Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils
58. Morphological changes in thrombocytes during blood bank storage. An ultrastructural morphometric study
59. Immunocytochemical localization of the chemokines RANTES and MIP-1 alpha within human platelets and their release during storage
60. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations
61. Cytokines in platelet concentrates prepared from pooled buffy coats
62. Low leukocyte contamination without filtration by preparation of platelet concentrates in cylindrical bags with the buffy-coat method
63. Megakaryocyte precursors, megakaryocytes and platelets express the HIV co-receptor CXCR4 on their surface: Determination of response to stromal-derived factor-1 by megakaryocytes and platelets
64. Stromal cell-derived factor-1 and macrophage-derived chemokine: 2 chemokines that activate platelets
65. Negatively charged leukocyte filter significantly enhances kallikrein and thrombin-like activities of platelet concentrates
66. RANTES, a monocyte and T lymphocyte chemotactic cytokine releases histamine from human basophils
67. New insights into the negative regulation of hematopoiesis by chemokine platelet factor 4 and related peptides
68. White blood cell subsets in buffy coat-derived platelet concentrates: The effect of pre- and poststorage filtration
69. Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defence cytokines: Interaction of NAP-2 with the NAP-1 receptor
70. Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
71. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2
72. Chemokines and their role in disease
73. Cytokine induction of platelet activation
74. The role of chemokines in atherosclerosis
75. Characterization of the human beta-thromboglobulin gene. Comparison with the gene for platelet factor 4
76. Increased plasma levels of the C-C chemokine RANTES in patients with primary HIV-1 infection
77. Low molecular weight heparins and heparin-induced thrombocytopenia
78. Chemokines and their receptors in infectious disease
79. The immunoelectron-microscopic localization of human platelet factor 4 in tissue mast cells
80. Complement activation in stored platelet concentrates
81. Neutrophil-activating properties of the melanoma growth-stimulatory activity
82. Roles of chemokines and chemokine receptors in HIV-1 infection
83. The molecular biology of leukocyte chemoattractant receptors
84. International union of pharmacology. XXII. Nomenclature for chemokine receptors
85. Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF alpha and IL-6 levels and febrile transfusion reactions
86. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates
87. Identification of a promiscuous inflammatory peptide receptor on the surface of red blood cells
88. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors
89. Cloning and characterization of a novel promiscuous human beta-chemokine receptor D6
90. Significance of chemokines and activated platelets in patients with diabetes
91. Platelets as inflammatory cells
92. The Duffy antigen/receptor for chemokines (DARC) is expressed in endothelial cells of Duffy negative individuals who lack the erythrocyte receptor
93. Platelet factor 4-induced neutrophil-endothelial cell interaction: Involvement of mechanisms and functional consequences different from those elicited by interleukin-8
94. TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines
95. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients
96. Chemokine and chemokine receptor mRNA expression in human platelets
97. Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets
98. Progressive platelet activation with storage: Evidence for shortened survival of activated platelets after transfusion
99. Activation in stored platelet concentrates: Correlation between membrane expression of P-selectin, glycoprotein IIb/IIIa, and beta-thromboglobulin release
100. Phenotypic and functional evidence for the expression of CXCR4 receptor during megakaryocytopoiesis
101. Chemokines
102. The biology of chemokines and their receptors
103. The relationship between the duration of platelet storage and the development of transfusion reactions
104. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
105. Platelets in ulcerative colitis and Crohn's disease express functional interleukin-1 and interleukin-8 receptors
106. The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages
107. Complement activation during storage of single-donor platelet concentrates
108. The storage quality of apheresis platelets - Analysis of results from seven different cell separators
109. Current methods for the preparation of platelet concentrates: Laboratory and clinical aspects
110. The platelet storage lesion
111. Cytokines in platelet concentrates: A comparison of apheresis platelet (haemonetics) and filtered and unfiltered pooled buffy-coat derived platelet concentrates
112. Chemotactic activity of platelet alpha granule proteins for fibroblasts
113. Compounds biologically similar to platelet activating factor are present in stored blood components
114. Long-term impaired neutrophil migration in mice overexpressing human interleukin-8
115. Cell type specific expression of members of the IL-8/NAP-1 gene family
116. Gene targeting of chemokines and their receptors
117. Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cell-reduction filter
118. Cytokine generation in stored platelet concentrates
119. ADP receptor antagonists inhibit platelet aggregation induced by the chemokines SDF-1, MDC and TARC
120. Chemokine production by human megakaryocytes derived from CD34-positive cord blood cells
121. Cytokine accumulation in stored red cell concentrates: Effect of buffy-coat removal and leucoreduction
122. Cytokines in WBC-reduced apheresis PCs during storage: A comparison of two WBC-reduction methods
123. Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays
124. Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases
125. Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8
126. Primary structure of human platelet factor 4
127. The alpha-chemokine receptor CXCR4 is expressed on the megakaryocytic lineage from progenitor to platelets and modulates migration and adhesion
128. Heparin-induced thrombocytopenia: Towards consensus
129. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
130. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates
131. Heterogeneity in storage pool deficiency: Studies on granule-bound substances in 18 patients including variants deficient in alpha-granules, platelet factor 4, beta-thromboglobulin, and platelet-derived growth factor
132. Cloning of cDNA coding for connective tissue activating peptide III from a human platelet-derived lambda gt11 expression library
133. Non-haemolytic transfusion reactions after platelet substitution
134. Impact of allergy screening for blood donors: Relationship to nonhemolytic transfusion reactions
135. Induction of members of the IL-8/NAP-1 gene family in human T lymphocytes is suppressed by cyclosporin A
136. Recent advances in chemokines and chemokine receptors
137. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
138. Platelet factor 4: Production, structure, and physiologic and immunologic action